This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Steffen Bjo Petersen: Innovator in Bacterial Alkaline Protease
Introduction
Steffen Bjo Petersen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of bacterial alkaline proteases. His work has implications for various industrial applications, including detergents and pharmaceuticals.
Latest Patents
Steffen Bjo Petersen holds a patent for "Useful mutations of bacterial alkaline protease." This invention relates to mutations of the subtilisin gene, which result in changes in the chemical characteristics of the subtilisin enzyme. The mutations are created at specific nucleic acids of the subtilisin gene, leading to mutant enzymes that possess altered chemical properties. These properties include increased stability to oxidation, augmented proteolytic activity, and improved washability. The patent also covers the amino acid and DNA sequences for two proteases derived from Bacillus lentus variants, subtilisin 147 and subtilisin 309, along with mutations of these genes and the corresponding mutant enzymes. He has 1 patent to his name.
Career Highlights
Steffen Bjo Petersen is associated with Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk has allowed him to work on innovative projects that enhance the functionality of enzymes used in various applications. His expertise in enzyme engineering has positioned him as a valuable asset in the biotechnology sector.
Collaborations
Steffen has collaborated with several talented individuals in his field, including Fanny Norris and Leif No slashedrskov-Lauridsen. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Steffen Bjo Petersen's contributions to the field of bacterial alkaline proteases highlight his innovative spirit and dedication to advancing biotechnology. His patent on useful mutations of the subtilisin gene showcases the potential for improved enzyme applications in various industries.